Return to program book search
Case-Based Approach to Common Cutaneous Lymphoma Patient Problems
Sunday, August 04
10:00 AM - 12:00 PM
Peter W. Heald, MD, FAAD
- Jo-Ann Latkowski, MD, FAAD
- Laura Pincus, MD, FAAD
- Brian Poligone, MD, PhD, FAAD
- Debjani Sahni, MBBS
Following this course, the attendee should be able to:
- Utilize clinical-pathological correlations to discern mycosis fungoides from its mimickers.
- Identify the diagnosis when the biopsy is "CD30 lymphoproliferative disorder."
- Determine whether an erythroderma is malignant or reactive.
Each of the presenters will present a common consultation from their CTCL clinic using a case based approach. How to deal with a biopsy that is "suggestive of CTCL" will be presented with a guide to the mimickers. In skin of color the dilemma of hypopigmented MF vs. mimicker will be presented with clinical-pathological correlations. Distinguishing a reactive from a malignant erythroderma is critical to deciding on whether or not to use immunosuppressive therapy. Likewise follicular mucinosis patients have clinical findings that can identify the severity of their eruption. CD30 Lymphoproliferative diseases can also be sorted by clinical features that are discussed.
|Sunday, August 04|
|10:00 AM||Introduction / Dr. Heald|
|10:05 AM||Is this dermatitis benign or malignant? / Dr. Latkowski|
|10:25 AM||Is this hypopigmentation from lymphoma or a nuisance? / Sahni|
|10:45 AM||Is this erythroderma malignant or reactive? / Dr. Pincus|
|11:05 AM||Which CD30 Lymphoproliferative Disorder is this? / Dr. Poligone|
|11:25 AM||Is this follicular mucinosis reactive or malignant? / Dr. Heald|